174740-64-8

Basic information

• Product Name: Benzoic acid, 2-[[[7-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]a mino]heptyl]amino]carbonyl]
• Synonyms: Benzoic acid, 2-[[[7-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]a mino]heptyl]amino]carbonyl]
• CAS NO: 174740-64-8
• Molecular Formula: C45H68 N2 O5
• Molecular Weight: 0
• Mol File: 174740-64-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 838.7°Cat760mmHg
• Flash Point: 461.1°C
• Appearance: /
• Density: 1.098g/cm³
• Vapor Pressure: 7.36E-30mmHg at 25°C
• Refractive Index: 1.549
• CAS DataBase Reference: Benzoic acid, 2-[[[7-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]a mino]heptyl]amino]carbonyl](CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-[[[7-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]a mino]heptyl]amino]carbonyl](174740-64-8)
• EPA Substance Registry System: Benzoic acid, 2-[[[7-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]a mino]heptyl]amino]carbonyl](174740-64-8)

Safety Data

• Hazardous Substances Data: 174740-64-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C45H68N2O5/c1-29(2)30-19-24-45(40(52)47-28-14-10-8-9-13-27-46-38(49)31-15-11-12-16-32(31)39(50)51)26-25-43(6)33(37(30)45)17-18-35-42(5)22-21-36(48)41(3,4)34(42)20-23-44(35,43)7/h11-12,15-16,30,33-37,48H,1,8-10,13-14,17-28H2,2-7H3,(H,46,49)(H,47,52)(H,50,51)/t30-,33+,34-,35+,36-,37+,42-,43+,44+,45-/m0/s1

Upstream product

• 59868-82-5 3-O-acetylbetulinic acid chloride 
• 161795-96-6 A₄₃-D 
• 646-19-5 heptane-1,7-diamine 
• 174740-37-5 Acetic acid (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[7-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-heptylcarbamoyl]-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysen-9-yl ester 

Relevant articles and documents

Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry

A novel series of ω-aminoalkanoic acid derivatives of betulinic acid were synthesized and evaluated for their activity against human immunodeficiency virus (HIV). The anti-HIV-1 activity of several members of this new series was found to be in the nanomolar range in CEM 4 and MT-4 cell cultures. The optimization of the ω-aminoalkanoic acid side chain is described. The presence of an amide function within the side chain was found important for optimal activity. RPR 103611 (14g), a statine derivative, was found to be inactive against HIV-1 protease, reverse transcriptase, and integrase as well as on gp120/CD4 binding. 'Time of addition' experiments suggested interaction with an early step of HIV-1 replication. As syncytium formation, but not virus-cell binding, seems to be affected, betulinic acid derivatives are assumed to interact with the postbinding virus-cell fusion process.